» Articles » PMID: 26903017

Resource Effective Strategies to Prevent and Treat Cardiovascular Disease

Overview
Journal Circulation
Date 2016 Feb 24
PMID 26903017
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries. The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in low- and middle-income countries. Barriers at the patient, healthcare provider, and health system level prevent the implementation of optimal primary and secondary prevention. Identification of the particular barriers that exist in resource-constrained settings is necessary to inform effective strategies to reduce the identified evidence-practice gaps. Furthermore, targeting modifiable factors that contribute most significantly to the global burden of CVD, including tobacco use, hypertension, and secondary prevention for CVD, will lead to the biggest gains in mortality reduction. We review a select number of novel, resource-efficient strategies to reduce premature mortality from CVD, including (1) effective measures for tobacco control, (2) implementation of simplified screening and management algorithms for those with or at risk of CVD, (3) increasing the availability and affordability of simplified and cost-effective treatment regimens including combination CVD preventive drug therapy, and (4) simplified delivery of healthcare through task-sharing (nonphysician health workers) and optimizing self-management (treatment supporters). Developing and deploying systems of care that address barriers related to the above will lead to substantial reductions in CVD and related mortality.

Citing Articles

An Insight to Nanoliposomes as Smart Radiopharmaceutical Delivery Tools for Imaging Atherosclerotic Plaques: Positron Emission Tomography Applications.

Sebatana R, Kudzai K, Magura A, Mdlophane A, Zeevaart J, Sathekge M Pharmaceutics. 2025; 17(2).

PMID: 40006607 PMC: 11858949. DOI: 10.3390/pharmaceutics17020240.


A Multi-Center, Prospective, Observational Study to Evaluate the Therapeutic Effectiveness and Safety of an Olmesartan/Amlodipine Plus Rosuvastatin Combination Treatment in Patients with Concomitant Hypertension and Dyslipidemia.

Lee B, Kim B, Park J, Chung J, Park C, Kim J J Clin Med. 2025; 14(2).

PMID: 39860313 PMC: 11765630. DOI: 10.3390/jcm14020308.


.

Wildner M Gesundheitswesen. 2025; 87(1):17-20.

PMID: 39814014 PMC: 11740221. DOI: 10.1055/a-2419-8655.


The Impact of 24 h Urinary Potassium Excretion on High-Density Lipoprotein Cholesterol and Chronic Disease Risk in Chinese Adults: A Health Promotion Study.

Du X, Chen X, Zhang J, Lu F, Xu C, Zhong J Nutrients. 2024; 16(19).

PMID: 39408253 PMC: 11478645. DOI: 10.3390/nu16193286.


Vascular medicine in the 21 century: Embracing comprehensive vasculature evaluation and multidisciplinary treatment.

Chaiter Y, Fink D, Machluf Y World J Clin Cases. 2024; 12(27):6032-6044.

PMID: 39328850 PMC: 11326099. DOI: 10.12998/wjcc.v12.i27.6032.


References
1.
Mckee M, Stuckler D, Basu S . Where there is no health research: what can be done to fill the global gaps in health research?. PLoS Med. 2012; 9(4):e1001209. PMC: 3335864. DOI: 10.1371/journal.pmed.1001209. View

2.
James P, Oparil S, Carter B, Cushman W, Dennison-Himmelfarb C, Handler J . 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2013; 311(5):507-20. DOI: 10.1001/jama.2013.284427. View

3.
Khatib R, Schwalm J, Yusuf S, Haynes R, Mckee M, Khan M . Patient and healthcare provider barriers to hypertension awareness, treatment and follow up: a systematic review and meta-analysis of qualitative and quantitative studies. PLoS One. 2014; 9(1):e84238. PMC: 3893097. DOI: 10.1371/journal.pone.0084238. View

4.
ODonnell M, Xavier D, Liu L, Zhang H, Chin S, Rao-Melacini P . Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010; 376(9735):112-23. DOI: 10.1016/S0140-6736(10)60834-3. View

5.
Sridhar D, Mckee M, Ooms G, Beiersmann C, Friedman E, Gouda H . Universal Health Coverage and the Right to Health: From Legal Principle to Post-2015 Indicators. Int J Health Serv. 2015; 45(3):495-506. DOI: 10.1177/0020731415584554. View